Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proliferative Nephritis”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Early research (Phase 1)Study completedNCT04128579
What this trial is testing

Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

Who this might be right for
Lupus ErythematosusLupus Nephritis
Biocon Limited 52
Testing effectiveness (Phase 2)Study completedNCT00001789
What this trial is testing

BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis

Who this might be right for
Glomerulonephritis, MembranoproliferativeLupus Nephritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Post-approval studies (Phase 4)Ended earlyNCT02226341
What this trial is testing

ACTHar in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Columbia University 8
Large-scale testing (Phase 3)Ended earlyNCT00430677
What this trial is testing

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 423
Post-approval studies (Phase 4)UnknownNCT02571842
What this trial is testing

Rituximab in Recurrent IgA Nephropathy

Who this might be right for
Recurrent IgA Nephropathy
Chulalongkorn University 30
Post-approval studies (Phase 4)UnknownNCT05495893
What this trial is testing

MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN

Who this might be right for
Mycophenolate MofetilCyclophosphamideLupus Nephritis
Second Xiangya Hospital of Central South University 224
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Large-scale testing (Phase 3)Study completedNCT00204022
What this trial is testing

Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Frédéric A. Houssiau, MD, PhD 105
Testing effectiveness (Phase 2)Study completedNCT04643470
What this trial is testing

Zanubrutinib in Participants With Active Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
BeiGene 177
Not applicableStudy completedNCT01269021
What this trial is testing

An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Zhi-Hong Liu, M.D. 176
Large-scale testing (Phase 3)Study completedNCT01042457
What this trial is testing

Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Chulalongkorn University 24
Testing effectiveness (Phase 2)Study completedNCT03610516
What this trial is testing

Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Study completedNCT03393013
What this trial is testing

KZR-616 in Patients With SLE With and Without Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Kezar Life Sciences, Inc. 69
Large-scale testing (Phase 3)Active Not RecruitingNCT07098897
What this trial is testing

To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
The Affiliated Hospital of Xuzhou Medical University 150
Very early researchNot Yet RecruitingNCT07389499
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases

Who this might be right for
IgA Nephropathy (IgAN)Membranous NephropathyANCA-associated Vasculitis (AAV)/ANCA-associated Glomerulonephritis (AAGN)+2 more
Grit Biotechnology 30
Testing effectiveness (Phase 2)Study completedNCT00976300
What this trial is testing

Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Institute of Rheumatology, Prague 40
Post-approval studies (Phase 4)Ended earlyNCT01861561
What this trial is testing

Low-dose VS High-dose IV Cyclophosphamide for Proliferative LN in Children

Who this might be right for
Renal InsufficiencyInfection
Mahidol University 43
Large-scale testing (Phase 3)Ended earlyNCT01015456
What this trial is testing

The Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) (Myfortic) in The Treatment of Relapse or Resistant Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Chulalongkorn University 59
Post-approval studies (Phase 4)Looking for participantsNCT05207358
What this trial is testing

Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Institutul Clinic Fundeni 30
Testing effectiveness (Phase 2)WithdrawnNCT05101447
What this trial is testing

Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Children's Hospital Medical Center, Cincinnati
Load More Results